Comparative safety and effectiveness of low-molecular-weight heparin, direct thrombin inhibitors, and factor Xa inhibitors for venous thromboembolism prophylaxis among patients with blunt trauma: a retrospective cohort study
BMC Surgery · 16.11.2026
DOI: 10.1186/s12893-026-04357-2 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift BMC Surgery, online erschienen am 16.11.2026. Verfasst von Jhih-Ming Tang und 8 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Themen: Thromboseprophylaxe
Abstract (Originalsprache)
Background
Venous thromboembolism (VTE) is a leading cause of preventable mortality among patients with trauma. Although low-molecular-weight heparin (LMWH) is the standard prophylactic agent, direct thrombin inhibitors (DTIs) and factor Xa inhibitors (FXaIs) offer potential alternatives. However, their comparative efficacy and safety among patients with blunt trauma remain unclear. This study aimed to compare the efficacy and safety of DTIs and FXaIs, using LMWH as the reference for VTE prophylaxis.
Methods
This retrospective cohort study was conducted using the American College of Surgeons Trauma Quality Improvement Program database between 2020 and 2022. Patients with blunt trauma and an Injury Severity Score ≥ 10 who received LMWH, DTIs, or FXaIs for VTE prophylaxis were included. Efficacy outcomes included deep vein thrombosis (DVT) and pulmonary embolism (PE). Safety outcomes evaluated were unplanned return to the operating room and in-hospital mortality. Multivariable logistic regression and 20:1 propensity score matching (PSM) adjusting for demographics, injury severity, comorbidities, and prophylaxis timing were performed to reduce potential confounding.
Results
Among 307,638 eligible patients, 305,049 received LMWH, 342 received DTIs, and 2247 received FXaIs. Compared to LMWH, DTIs were associated with significantly higher odds of DVT (odds ratio [OR] 3.62; 95% confidence interval [CI] 2.25–5.84), PE (OR 3.46; 95% CI 1.75–6.82), unplanned return to the operating room (OR 2.08; 95% CI 1.22–3.54), and mortality (OR 1.70; 95% CI 1.10–2.64). FXaIs also increased the odds of DVT (OR 2.79; 95% CI 2.19–3.56) and PE (OR 3.40; 95% CI 2.53–4.57) compared to LMWH; however, no significant difference was observed in unplanned return to the operating room (OR 0.74; 95% CI 0.50–1.09) or mortality (OR 1.06; 95% CI 0.83–1.36). Consistent findings were confirmed in the PSM cohort, where DTI retained significantly increased odds of VTE and unplanned return to the operating room, while FXaIs showed comparable safety profiles to LMWH.
Conclusions
LMWH was associated with lower odds of VTE than DTIs and FXaIs, and DTIs were additionally associated with higher odds of unplanned return to the operating room. FXaIs showed safety outcomes comparable to LMWH and may be considered when LMWH cannot be used. Further prospective studies are needed to guide agent selection in specific clinical scenarios.
Zitieren
APA
Tang, J., Huang, S., Hu, C., Chai, S., Tung, H., Huang, J., Cheng, C., Liao, C., & Hsu, C. (2026). Comparative safety and effectiveness of low-molecular-weight heparin, direct thrombin inhibitors, and factor Xa inhibitors for venous thromboembolism prophylaxis among patients with blunt trauma: a retrospective cohort study. BMC Surgery. https://doi.org/10.1186/s12893-026-04357-2
Vancouver
Tang J, Huang S, Hu C, Chai S, Tung H, Huang J, et al. Comparative safety and effectiveness of low-molecular-weight heparin, direct thrombin inhibitors, and factor Xa inhibitors for venous thromboembolism prophylaxis among patients with blunt trauma: a retrospective cohort study. BMC Surgery. 2026. doi:10.1186/s12893-026-04357-2
BibTeX
@article{Tang2026,
author = {Tang, Jhih-Ming and Huang, Shu-Yi and Hu, Chia-Hsiang and Chai, Shion-Wei and Tung, Hsuan-Fan and Huang, Jen-Fu and Cheng, Chi-Tung and Liao, Chien-Hung and Hsu, Chih-Po},
title = {Comparative safety and effectiveness of low-molecular-weight heparin, direct thrombin inhibitors, and factor Xa inhibitors for venous thromboembolism prophylaxis among patients with blunt trauma: a retrospective cohort study},
journal = {BMC Surgery},
year = {2026},
doi = {10.1186/s12893-026-04357-2}
}
EUVIMED